(5S,9S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,9-diisopropyl-12-Methoxy-4,10-diMethyl-3,6,8-trioxo-2-oxa-4,7,10-triazatetradecan-14-oic acid
(5S,9S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,9-diisopropyl-12-Methoxy-4,10-diMethyl-3,6,8-trioxo-2-oxa-4,7,10-triazatetradecan-14-oic acid is a cleavable ADC linker for antibody-drug conjugate (ADC) synthesis.
| Catalog Number | INT863971442 |
| Alternative Name(s) | Fmoc-3AA-orl;FMOC-3AA-OH;Fmoc-3vvd-OH;Tripeptide (MMAE-3);Fmoc-Meval-val-dolaisoleucine-OH;(5S,8S,11S,12R)-11-((S)-sec-butyl)-1-(9H-fluoren-9-yl)-5,8-diisopropyl-12-methoxy-4,10-dimethyl-3,6,9-trioxo-2-oxa-4,7,10-triazatetradecan-14-oic acid;L-Valinamide, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N-methyl-L-valyl-N-[(1S,2S)-1-[(1R)-2-carboxy-1-methoxyethyl]-2-methylbutyl]-N-methyl- |
| Research Area | Intermediates |
| Molecular Formula | C36H51N3O7 |
| CAS# | 863971-44-2 |
| Purity | 0.97% |
| Inchi Key | JDMOCVJBADMSJP-FCUBIXSHSA-N |
| SMILES | C(NC(=O)[C@H](C(C)C)N(C(OCC1C2=C(C=CC=C2)C2=C1C=CC=C2)=O)C)(=O)[C@H](C(C)C)N([C@H]([C@H](OC)CC(O)=O)[C@@H](C)CC)C |
| Size | inquiry |
| Supplier Page | https://www.protheragen-ing.com/5s9s11s12r-11-s-sec-butyl-1-9h-fluoren-9-yl-59-diisopropyl-12-methoxy-410-dimethyl-368-trioxo-2-oxa-4710-triazatetradecan-14-oic-acid-item-7145.html |